The Continuing Quandary: What’s New About Hormonal Contraception And HIV?
Concern continues that certain hormonal contraceptive methods may increase the risk of HIV acquisition among women at high risk of HIV. The risk of HIV acquisition with the use of hormonal contraceptive is of major public health importance, especially in sub-Saharan Africa where there are high rates of progestogen-only injectables use and high prevalence and incidence of HIV. This year, the World Health Organization issued revised guidance on use of injectable contraception for women at high risk of HIV. This session will review the updated but still uncertain evidence and engage participants in an interactive session to discuss implications for policy, programs and future research priorities.
Speakers: Abdulmumin Saad, USAID; Tabitha Sripipatana, USAID